Viartis discussed the positive study results from
Post# of 30028
Posted On: 02/17/2015 12:08:28 PM
Re: Both shallow #16840
Viartis discussed the positive study results from Amarantus' Eltoprazine clinical trial published in BRAIN. Viartis highlighted that 5mg of Eltoprazine caused a significant reduction of L-dopa induced dyskinesias , as well as an antidyskinetic effect with 7.5 mg. Full study abstract and additional Parkinson's news available here: http://bit.ly/1yLLtG2
Read More: http://investorshangout.com/post/view?id=2681...z3S1UE1ffw
" This is blockbuster news" Eltoprazine needs FDA approval"
Read More: http://investorshangout.com/post/view?id=2681...z3S1UE1ffw
" This is blockbuster news" Eltoprazine needs FDA approval"
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼